Evidence map›Paper›PMID 38247645›Full record

ArticleAntibiotics (Basel, Switzerland)2024

Fighting Microbial Infections from

Raffaella Scotti, Bruno Casciaro, Annarita Stringaro, Filippo Maggi, Marisa Colone, Roberta Gabbianelli

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Bacterial persisters: molecular mechanisms and therapeutic development.Signal transduction and targeted therapy · 2024
    Review
  4. Biosynthesized silver nanoparticles prevent bacterial infection in chicken egg model and mitigate biofilm formation on medical catheters.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Raffaella ScottiBiological Service, Italian National Institute of Health, 00161 Rome, Italy.ORCID 0000-0002-4753-1429
Bruno CasciaroLaboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Biochemical Sciences, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0003-1295-1084
Annarita StringaroNational Center for Drug Research and Evaluation, Italian National Institute of Health, 00161 Rome, Italy.ORCID 0000-0002-0143-2978
Filippo MaggiChemistry Interdisciplinary Project (ChIP) Research Center, School of Pharmacy, University of Camerino, 62032 Camerino, Italy.ORCID 0000-0003-1375-4744
Marisa ColoneNational Center for Drug Research and Evaluation, Italian National Institute of Health, 00161 Rome, Italy.ORCID 0000-0002-7522-7483
Roberta GabbianelliBiological Service, Italian National Institute of Health, 00161 Rome, Italy.ORCID 0000-0001-6541-1386
National Institute of Health · AMIstituto Pasteur · ITUniversità di Camerino · IT

Funding

Italian National Institute of Health ISS20-b4aee634f6c5
6 · The paper itself

Abstract

The absence of effective therapy against

Indexed as

antibacterial activityantimicrobial peptidesbiofilmCymbopogon genusEscherichia coli O157:H7esculentin-1aessential oilsynergism

Identifiers

PMID38247645
PMCPMC10812396
OpenAlexW4390910461

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.